Pasqal Holding SA (NASDAQ:PSQL – Get Free Report) has earned an average recommendation of “Buy” from the six analysts that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $16.00.
PSQL has been the topic of several research reports. Williams Trading set a $16.00 price target on shares of Pasqal in a report on Wednesday, September 30th. Zacks Research upgraded Pasqal to a “hold” rating in a report on Thursday, September 24th. Roth Capital initiated coverage on Pasqal in a research report on Wednesday, September 9th. They issued a “buy” rating and a $20.00 price objective on the stock. Canaccord Genuity Group reissued a “buy” rating and set a $16.00 price target on shares of Pasqal in a research report on Monday, September 28th. Finally, Benchmark raised shares of Pasqal to a “strong-buy” rating in a research report on Tuesday, October 6th.
View Our Latest Research Report on Pasqal
Pasqal Trading Down 18.5%
NASDAQ PSQL opened at $4.11 on Friday. The company has a current ratio of 2.22, a quick ratio of 2.04 and a debt-to-equity ratio of 0.13. The stock’s 50-day simple moving average is $6.53. Pasqal has a twelve month low of $4.11 and a twelve month high of $24.69.
About Pasqal
Pasqal is a France-based quantum computing company that develops quantum processors, software and application solutions based on neutral-atom technology. Its systems use individually controlled atoms to perform quantum computations and are designed to address complex problems that can be difficult to solve with conventional computing.
The company provides quantum computing hardware and access to its technology through cloud-based platforms, along with software tools that enable customers and researchers to develop, test and run quantum algorithms.
Recommended Stories
- Five stocks we like better than Pasqal
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Pasqal Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pasqal and related companies with MarketBeat.com's FREE daily email newsletter.
